Retrospective analysis of interventional treatment of hepatic metastasis from gastroenteropancreatic neuroendocrine tumors

被引:1
|
作者
Peng Liu [1 ]
Xu Zhu [1 ]
Jie Li [2 ]
Ming Lu [2 ]
Jiahua Leng [3 ]
Ying Li [4 ]
Jiangyuan Yu [5 ]
机构
[1] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Interventional Therapy,Peking University Cancer Hospital & Institute
[2] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Gastroenterological Oncology,Peking University Cancer Hospital & Institute
[3] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Center of Gastrointestinal Surgery Unit Ⅲ,Peking University Cancer Hospital & Institute
[4] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Radiology,Peking University Cancer Hospital & Institute
[5] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Nuclear Medicine,Peking University Cancer Hospital & Institute
基金
中国国家自然科学基金;
关键词
Gastroenteropancreatic neuroendocrine tumors; hepatic metastasis; angiography; interventional treatment; retrospective analysis;
D O I
暂无
中图分类号
R735 [消化系肿瘤];
学科分类号
摘要
Objective: To analyze the angiography appearance of liver metastases from gastroenteropancreatic neuroendocrine tumors(GEP-NETs),and evaluate the clinical efficacy and prognostic factors of interventional treatment for hepatic metastases.Methods: Fifty GEP-NETs patients with hepatic metastases were treated from January 2012 to December 2016,and received transarterial embolization(TAE) in the hepatic tumor or hepatic arterial infusion chemotherapy(HAIC).All patients received 179 times of the intervention therapy in total.Results: Blood supplies were identified in the 50 cases with angiography,which showed that 35 cases had abundant vessels,while 15 cases had poor blood supply.Twenty-two cases were found either collateral blood supply,or portal vein invasion or arterial-portal vein fistula.The best curative efficacy was complete remission(CR)in 4 cases,partial remission(PR) in 28 cases and stable disease(SD) in 18 cases during the process of treatment.The angiography(P=0.047) and the frequency of intervention(P=0.037) showed significantly statistical difference with Kaplan-Meier analysis.The Cox analysis showed that more than 3 times of interventional therapy was an independent prognostic factor.Conclusions: Interventional treatment is safe and effective for GEP-NETs,and is beneficial to patients with main hepatic metastases after endocrine therapy.
引用
收藏
页码:581 / 586
页数:6
相关论文
共 50 条
  • [1] Retrospective analysis of interventional treatment of hepatic metastasis from gastroenteropancreatic neuroendocrine tumors
    Liu, Peng
    Zhu, Xu
    Li, Jie
    Lu, Ming
    Leng, Jiahua
    Li, Ying
    Yu, Jiangyuan
    CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (06) : 581 - 586
  • [2] Treatment of Hepatic Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Role of Liver Transplantation
    Burckhardt Ringe
    Thomas Lorf
    Karen Döpkens
    Ruben Canelo
    World Journal of Surgery, 2001, 25 : 697 - 699
  • [3] Treatment of hepatic metastases from gastroenteropancreatic neuroendocrine tumors:: Role of liver transplantation
    Ringe, B
    Lorf, T
    Döpkens, K
    Canelo, R
    WORLD JOURNAL OF SURGERY, 2001, 25 (06) : 697 - 699
  • [4] Treatment of gastroenteropancreatic neuroendocrine tumors
    U. Plöckinger
    B. Wiedenmann
    Virchows Archiv, 2007, 451 : 71 - 80
  • [5] Treatment of gastroenteropancreatic neuroendocrine tumors
    Ploeckinger, U.
    Wiedenmann, B.
    VIRCHOWS ARCHIV, 2007, 451 (Suppl 1) : S71 - S80
  • [6] Application of Machine Learning in Predicting Hepatic Metastasis or Primary Site in Gastroenteropancreatic Neuroendocrine Tumors
    Padwal, Mahesh Kumar
    Basu, Sandip
    Basu, Bhakti
    CURRENT ONCOLOGY, 2023, 30 (10) : 9244 - 9261
  • [7] Hepatic Metastases of Gastroenteropancreatic Neuroendocrine Tumors: Safe Hepatic Surgery
    Daniel Jaeck
    Ph. D.
    Elie Oussoultzoglou
    Philippe Bachellier
    Pascal Lemarque
    Jean-Christophe Weber
    Hiroshi Nakano
    Ph. D.
    Philippe Wolf
    Ph. D.
    World Journal of Surgery, 2001, 25 : 689 - 692
  • [8] Lanreotide for the treatment of gastroenteropancreatic neuroendocrine tumors
    Saif, Muhammad Wasif
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (03) : 443 - 456
  • [9] Hepatic metastases of gastroenteropancreatic neuroendocrine tumors: Safe hepatic surgery
    Jaeck, D
    Oussoultzoglou, E
    Bachellier, P
    Lemarque, P
    Weber, JC
    Nakano, H
    Wolf, P
    WORLD JOURNAL OF SURGERY, 2001, 25 (06) : 689 - 692
  • [10] Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Tumors
    Phan, Alexandria T.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (12) : 3 - 5